Raptor Submits IND for RP103 for Leigh Syndrome and Other Mitochondrial Disorders
December 10, 2013 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Dec. 10, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it has submitted an investigational new drug application (IND) to the U.S. Food and...